Physical therapy isn't only for athletes. Anyone who needs help meeting movement goals and regaining independence can benefit ...

Dr. Fox Remains a Shareholder and Member of the Board of Directors; Board Members Dr. David McFarland & Dr. Lorraine ...

Recommendations for RehabilitationWhen you hear the word "rehabilitation," what comes to mind?If you have spondyloarthritis, ...

On Monday, Sept. 28, the U.S. Food and Drug Administration approved a new treatment that targets dopamine pathways critical ...

AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved JUVMO™ (tavapadon) tablets as the first and only selective D1/D5 receptor agonist for the treatment of ...

ABBV wins FDA approval for Juvmo, expanding its Parkinson's portfolio with a once-daily oral treatment and potential $5B-plus ...

Juvmo (tavapadon) offers a novel, selective D1/D5 dopamine receptor partial agonist mechanism for early monotherapy and adjunctive treatment in Parkinson disease.

AbbVie has won U.S. Food and Drug Administration approval of its Juvmo once-daily oral treatment for the progressive neurological disorder Parkinson's disease. AbbVie on Monday said the green light ...

Santana is a 4-month-old domestic shorthair cat and she's available for adoption at the Belleville Area Humane Society, located at 1301 South 11th Street. The BAHS is open Tuesday through Saturday, 10 ...